EGLN3 and acute myeloid leukemia: Based on the findings that Hif depletion accelerates AML disease progression in mice (51–53) and inhibition of other EGLN family members efficiently compromises AML development (54), we hypothesized that Egln3 upregulation in AML cells could promote AML progression.